Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AKL1 Asthma Study - Randomised, Double-Blind, Placebo Controlled, Cross Over Study to Determine Safety and Efficacy of Oral AKL1 in Treating Patients With Asthma

NCT00407524 is registered in ClinicalTrials.gov with University of Aberdeen as lead sponsor.

NCT NCT00407524
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00407524 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AKL1 Asthma Study - Randomised, Double-Blind, Placebo Controlled, Cross Over Study to Determine Safety and Efficacy of Oral AKL1 in Treating Patients With Asthma
Lead sponsor
University of Aberdeen
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2003
Completion date
March 31, 2005
Enrollment
40
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma